Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer.

Kim SM, Kang HW, Kim WT, Kim YJ, Yun SJ, Lee SC, Kim WJ.

Korean J Urol. 2013 Nov;54(11):791-6. doi: 10.4111/kju.2013.54.11.791. Epub 2013 Nov 6.

PMID:
24255763
[PubMed]
Free PMC Article
2.

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer.

Yun SJ, Jeong P, Kim WT, Kim TH, Lee YS, Song PH, Choi YH, Kim IY, Moon SK, Kim WJ.

Int J Oncol. 2012 Nov;41(5):1871-8. doi: 10.3892/ijo.2012.1622. Epub 2012 Sep 6.

PMID:
22961325
[PubMed - indexed for MEDLINE]
3.

mRNA Expression of S100A8 as a Prognostic Marker for Progression of Non-Muscle-Invasive Bladder Cancer.

Ha YS, Kim MJ, Yoon HY, Kang HW, Kim YJ, Yun SJ, Lee SC, Kim WJ.

Korean J Urol. 2010 Jan;51(1):15-20. doi: 10.4111/kju.2010.51.1.15. Epub 2010 Jan 21.

PMID:
20414404
[PubMed]
Free PMC Article
4.

microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.

Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I.

Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.

PMID:
23169479
[PubMed - indexed for MEDLINE]
5.

Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.

Shim UJ, Lee IS, Kang HW, Kim J, Kim WT, Kim IY, Ryu KH, Choi YH, Moon SK, Kim YJ, Yun SJ, Lee SC, Kim WJ.

Korean J Urol. 2013 Sep;54(9):631-7. doi: 10.4111/kju.2013.54.9.631. Epub 2013 Sep 10.

PMID:
24044099
[PubMed]
Free PMC Article
6.

Is urinary soluble Fas an independent predictor of non-muscle-invasive bladder cancer? A prospective chart study.

Yang H, Li H, Wang Z, Gao J, Guo Y.

Urol Int. 2013;91(4):456-61. doi: 10.1159/000350752. Epub 2013 Aug 14.

PMID:
23948854
[PubMed - indexed for MEDLINE]
7.

Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.

Shelley MD, Jones G, Cleves A, Wilt TJ, Mason MD, Kynaston HG.

BJU Int. 2012 Feb;109(4):496-505. doi: 10.1111/j.1464-410X.2011.10880.x. Review.

PMID:
22313502
[PubMed - indexed for MEDLINE]
8.

Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.

Kim JS, Chae Y, Ha YS, Kim IY, Byun SS, Yun SJ, Kim WJ.

Clin Genitourin Cancer. 2012 Jun;10(2):114-20. doi: 10.1016/j.clgc.2011.12.003. Epub 2012 Feb 28.

PMID:
22382007
[PubMed - indexed for MEDLINE]
9.

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer.

Wang S, Xue S, Dai Y, Yang J, Chen Z, Fang X, Zhou W, Wu W, Li Q.

Diagn Pathol. 2012 Nov 22;7:159. doi: 10.1186/1746-1596-7-159.

PMID:
23173870
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?

Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J.

World J Urol. 2014 Apr;32(2):353-8. doi: 10.1007/s00345-012-1010-2. Epub 2012 Dec 25.

PMID:
23266581
[PubMed - in process]
11.

Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.

Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ.

Urology. 2010 Jun;75(6):1516.e9-13. doi: 10.1016/j.urology.2009.08.055. Epub 2009 Nov 13.

PMID:
19913893
[PubMed - indexed for MEDLINE]
12.

Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.

Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C.

Int J Cancer. 2014 Jun 24. doi: 10.1002/ijc.29041. [Epub ahead of print]

PMID:
24961907
[PubMed - as supplied by publisher]
13.

Predicting progression of bladder urothelial carcinoma using microRNA expression.

Rosenberg E, Baniel J, Spector Y, Faerman A, Meiri E, Aharonov R, Margel D, Goren Y, Nativ O.

BJU Int. 2013 Nov;112(7):1027-34. doi: 10.1111/j.1464-410X.2012.11748.x. Epub 2013 Feb 6.

PMID:
23387295
[PubMed - indexed for MEDLINE]
14.

Aberrant Methylation of CDH13 is a Potential Biomarker for Predicting the Recurrence and Progression of Non Muscle Invasive Bladder Cancer.

Lin YL, Xie PG, Ma JG.

Med Sci Monit. 2014 Sep 4;20:1572-7. doi: 10.12659/MSM.892130.

PMID:
25196672
[PubMed - in process]
Free PMC Article
15.

Identification of C16orf74 as a marker of progression in primary non-muscle invasive bladder cancer.

Kim WT, Yun SJ, Park C, Kim IY, Moon SK, Kwon TG, Choi YH, Kim WJ.

PLoS One. 2010 Dec 21;5(12):e15260. doi: 10.1371/journal.pone.0015260.

PMID:
21203532
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer.

Yun SJ, Jo SW, Ha YS, Lee OJ, Kim WT, Kim YJ, Lee SC, Kim WJ.

Urol Oncol. 2012 Nov-Dec;30(6):893-9. doi: 10.1016/j.urolonc.2010.08.018. Epub 2011 Mar 10.

PMID:
21396842
[PubMed - indexed for MEDLINE]
17.

Platelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer.

Feng J, He W, Song Y, Wang Y, Simpson RJ, Zhang X, Luo G, Wu J, Huang C.

PLoS One. 2014 May 6;9(5):e96671. doi: 10.1371/journal.pone.0096671. eCollection 2014.

PMID:
24801713
[PubMed - in process]
Free PMC Article
18.

Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: a retrospective cohort study.

Hwang EC, Kim YJ, Hwang IS, Hwang JE, Jung SI, Kwon DD, Park K, Ryu SB.

Int J Urol. 2011 Nov;18(11):769-76. doi: 10.1111/j.1442-2042.2011.02845.x. Epub 2011 Sep 13.

PMID:
21914000
[PubMed - indexed for MEDLINE]
19.

RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.

Yan C, Kim YW, Ha YS, Kim IY, Kim YJ, Yun SJ, Moon SK, Bae SC, Kim WJ.

J Surg Oncol. 2012 Mar 15;105(4):425-30. doi: 10.1002/jso.22087. Epub 2011 Aug 30.

PMID:
22311819
[PubMed - indexed for MEDLINE]
20.

Intravesical gemcitabine for non-muscle invasive bladder cancer.

Jones G, Cleves A, Wilt TJ, Mason M, Kynaston HG, Shelley M.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD009294. doi: 10.1002/14651858.CD009294.pub2. Review.

PMID:
22259002
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk